Ensuring Access to Optimal Therapy in CF: The ENACT Study

Conditions

• Cystic Fibrosis (CF)

Interventions

• DRUG: Elexacaftor / Ivacaftor / Tezacaftor
• OTHER: therapeutic drug monitoring

Sponsor

Arkansas Children's Hospital Research Institute

Collaborators

• [object Object]
• [object Object]